Bayer AG (BAYZF)
30.24
-0.22
(-0.72%)
USD |
OTCM |
May 03, 16:00
Bayer Price to Book Value: 0.8162 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.8162 |
| May 02, 2024 | 0.8222 |
| May 01, 2024 | 0.7909 |
| April 30, 2024 | 0.7958 |
| April 29, 2024 | 0.7868 |
| April 26, 2024 | 0.7849 |
| April 25, 2024 | 0.7824 |
| April 24, 2024 | 0.7819 |
| April 23, 2024 | 0.7903 |
| April 22, 2024 | 0.7848 |
| April 19, 2024 | 0.7613 |
| April 18, 2024 | 0.7539 |
| April 17, 2024 | 0.7598 |
| April 16, 2024 | 0.7398 |
| April 15, 2024 | 0.7557 |
| April 12, 2024 | 0.7792 |
| April 11, 2024 | 0.786 |
| April 10, 2024 | 0.798 |
| April 09, 2024 | 0.7984 |
| April 08, 2024 | 0.7995 |
| April 05, 2024 | 0.8602 |
| April 04, 2024 | 0.8282 |
| April 03, 2024 | 0.8308 |
| April 02, 2024 | 0.8135 |
| April 01, 2024 | 0.8259 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.8311 |
| March 27, 2024 | 0.8309 |
| March 26, 2024 | 0.7938 |
| March 25, 2024 | 0.7879 |
| March 22, 2024 | 0.779 |
| March 21, 2024 | 0.7798 |
| March 20, 2024 | 0.7581 |
| March 19, 2024 | 0.7598 |
| March 18, 2024 | 0.7717 |
| March 15, 2024 | 0.7706 |
| March 14, 2024 | 0.7639 |
| March 13, 2024 | 0.7844 |
| March 12, 2024 | 0.7786 |
| March 11, 2024 | 0.7917 |
| March 08, 2024 | 0.7736 |
| March 07, 2024 | 0.7782 |
| March 06, 2024 | 0.7814 |
| March 05, 2024 | 0.7625 |
| March 04, 2024 | 0.8232 |
| March 01, 2024 | 0.8281 |
| February 29, 2024 | 0.8208 |
| February 28, 2024 | 0.8371 |
| February 27, 2024 | 0.838 |
| February 26, 2024 | 0.838 |
| February 23, 2024 | 0.8404 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7398
Minimum
Apr 16 2024
1.833
Maximum
Jul 06 2020
1.380
Average
1.417
Median
Mar 31 2023
Price to Book Value Benchmarks
| Fresenius Medical Care AG | 0.8173 |
| Affimed NV | 1.292 |
| InflaRx NV | 0.7166 |
| MorphoSys AG | 49.78 |
Price to Book Value Related Metrics
| PS Ratio | 0.5765 |
| Price to Free Cash Flow | 11.60 |
| Price | 30.24 |
| Earnings Yield | -10.94% |
| Market Cap | 29.71B |
| Operating PE Ratio | 3.458 |